We are live on
!
Find out more
BAM
Bedlam Asset Management Portfolio holdings
AUM
$126M
This Fund
S&P 500
This Quarter
Est. Return
+2.94%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$134M
AUM Growth
–
Cap. Flow
+$129M
Cap. Flow
% of AUM
96.43%
Top 10 Holdings %
Top 10 Hldgs %
79.16%
Holding
23
New
23
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$13.4M |
| 2 |
Chart Industries
GTLS
|
+$11.8M |
| 3 |
Pentair
PNR
|
+$11.4M |
| 4 |
Morningstar
MORN
|
+$11.3M |
| 5 |
Medtronic
MDT
|
+$11.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.42% |
| 2 | Healthcare | 25.31% |
| 3 | Technology | 14.13% |
| 4 | Materials | 8.48% |
| 5 | Consumer Discretionary | 7.5% |
Similar funds
TBA
SAM
SC
SIIU
PFS
SFS
GMAV
GGCMI
Bedlam Asset Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Bedlam Asset Management, which disclosed 23 positions worth $134M. Its ten largest holdings account for 79% of the portfolio.
Its largest position is Pfizer: 486,206 shares worth $12.9M.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, followed by Healthcare and Technology.
- Bedlam Asset Management's largest Q2 2013 buy was Pfizer: 486,206 shares worth $12.9M.
- Bedlam Asset Management's ten largest holdings make up 79% of its $134M portfolio in Q2 2013.
- Bedlam Asset Management disclosed 23 positions in Q2 2013, its first 13F filing on record.
Based on Bedlam Asset Management's 13F filing for Q2 2013, filed 14 Aug 2013.